189894-57-3

Basic information

• Product Name: Traxoprodil mesylate, CP-101606-27
• Synonyms: Traxoprodil mesylate, CP-101606-27;(alphaS,beta S)-4-Hydroxy-alpha-(4-hydroxyphenyl)-beta-methyl-4-phenyl-1-piperidineethanol methanesulfonate hydrate;Traxoprodil mesylate hydrate;1-((1S,2S)-1-Hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol Methanesulfonate trihydrate;(S,S)-1-(4-Hydroxyphenyl)-2-[4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate
• CAS NO: 189894-57-3
• Molecular Formula: C21H35NO9S
• Molecular Weight: 477.5689
• EINECS: -0
• Mol File: 189894-57-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Traxoprodil mesylate, CP-101606-27(CAS DataBase Reference)
• NIST Chemistry Reference: Traxoprodil mesylate, CP-101606-27(189894-57-3)
• EPA Substance Registry System: Traxoprodil mesylate, CP-101606-27(189894-57-3)

Safety Data

• Hazardous Substances Data: 189894-57-3(Hazardous Substances Data)

Usage

Description

Traxoprodil mesylate, CP-101606-27, is a potent and selective antagonist of the N-methyl-D-aspartate receptor (NMDAR) subtype called NR2B. This chemical compound is primarily used for research purposes, particularly in the study of neurobiology and neuropharmacology. It functions by blocking specific NMDA receptors that are essential for various brain functions, such as memory and learning.

Uses

Used in Neurobiology Research:
Traxoprodil mesylate, CP-101606-27, is used as a research tool for investigating the role of NMDA receptors in neurobiology. Its ability to selectively block the NR2B subtype of NMDA receptors helps researchers understand the underlying mechanisms of memory, learning, and other cognitive processes.
Used in Neuropharmacology Research:
In neuropharmacology, Traxoprodil mesylate, CP-101606-27, is used as a research compound to study the effects of NMDA receptor antagonism on various neurological conditions. This helps in the development of potential therapeutic strategies for treating neurological disorders.
Used in Potential Therapeutic Applications:
Traxoprodil mesylate, CP-101606-27, is being investigated for its potential use in treating conditions such as neuropathic pain, Parkinson's disease, and depression. Its ability to block NMDA receptors may offer therapeutic benefits in these areas, but further medical and clinical research is required to fully understand its potential uses and effects.